Point72 Takes a 5% Stake in SNDX
Point72 Asset Management LP filed a 13G for Syndax Pharmaceuticals $SNDX revealing an initial stake of 5.10%.
Here’s The Hot Corner, with data through October 31, 2023:
In another Form 4, director Linda K. Zukauckas revealed a purchase of $102,507 in TransUnion $TRU.
In the options market, there was bullish flow in Anavex Life Sciences Corp $AVXL, Ferroglobe PLC $GSM, and IHS Holding Limited $IHS.
Stay tuned. We'll be back on Thursday with more insider activity.
If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.
And please reach out with any questions. We love hearing from you!
All Star Charts Team